Pluxee Stock Drops Nearly 4%, Following Edenred at the Bottom of the SBF 120
The employee benefits specialist gives back some of its gains from the previous session at the Paris Stock Exchange. The stock follows the movement of its competitor Edenred, which is also penalized during the session. The value is among the largest declines of the broader index.
The stock returns to its 20-day moving average after its rebound
Pluxee's stock drops 3.76% to €11.53, down from €11.98 the previous day. The decline comes after a surge of 6.5% fueled by merger rumors surrounding Edenred, the group's direct competitor. Today, Edenred is down 4.42%, trailing at the bottom of the SBF 120, while Pluxee holds the penultimate position in the ranking. Despite this, the broader index is up 0.3% during the session, highlighting the contrast.
The movement brings the price right back to its 20-day moving average at €11.53, after having crossed it significantly higher on Thursday. The MM50 at €11.79 and the MM200 at €12.80 remain above the price, with a gap of 9.92% for the latter, indicating a deteriorating medium-term trend. The RSI at 60 remains neutral, with no particular signs of exhaustion. The support at €10.96 will mark the next technical reference point if the selling pressure continues.
A positive short-term dynamic countered by a still negative long-term trend
Despite the session, the stock maintains a weekly performance of 5.2% and a gain of 11.72% over three months. However, the annual performance remains very unfavorable, with a decline of 36.33% over twelve months, reflecting the mistrust that has been in place since the summer of 2025. Based on the consensus of analysts surveyed, the stock is trading at approximately 7.7 times the expected earnings for the current fiscal year, a modest multiple that reflects the market's caution about the earnings trajectory.
The co-movement with Edenred illustrates the sectoral reading imposed by operators over several sessions: the two issuers of meal vouchers and gift certificates react together to the rumors and denials that punctuate the merger case. The behavior of the price around €11.53 remains the immediate reference, with the support at €10.96 as the next identified level in the data.
